Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
Patients age 65+ cite efficiency and preference over traditional paper-based consentingPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, achieved an impressive 75% adoption of its Total Conse...